Altitude Lab
Accelerator/Incubator
Active
Salt Lake City, United States
7
7
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Preferences and restrictions
- Restriction
- We are currently not accepting device and tools companies unless they are pursuing a combination therapeutic-device model // Representative & inclusive teams: While we have no absolute quotas or requirements of individual startups, Altitude Lab aims for 50% of our startups to have at least one underrepresented founder or executive. We do require all companies to make a commitment to build inclusive businesses. Preference for grants will be given to exceptional leaders from historically underrepresented backgrounds // Stage: Early stage companies with 5 or fewer employees and a soft limit of $2M in equity-based funding or annual revenue.
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Investments by industry
- Medical (6)
- Health Care (5)
- Biotechnology (4)
- Therapeutics (1)
- Life Science (1) Show 2 more
- Investments by region
-
- United States (7)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 2
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Teiko.bio | 29 Mar 2022 | Biotechnology, Health Care, Health Diagnostics, Medical | Seed | Salt Lake City, Utah, United States |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.